MEDNAX, Inc. (NYSE: MD), the national medical group providing hospital-based neonatal, anesthesia and pediatric physician services and office-based maternal-fetal and pediatric cardiology physician services, reported earnings per share for the three months ended December 31, 2009, of $1.07 on a GAAP basis, or $1.00 per share when adjusted to exclude the favorable impact of a [...]

Continue reading " MEDNAX Reports GAAP EPS of $1.07 for 2009 Fourth Quarter "

Health Care REIT, Inc. (NYSE:HCN) announced that it completed $208.9 million of gross investments during the fourth quarter of 2009. During the quarter, the company had dispositions of $127.4 million, resulting in net new investments of $81.5 million. For the twelve months ended December 31, 2009, the company completed $716.6 million of gross investments, offset [...]

Continue reading " Health Care REIT, Inc. Announces Gross Investments of $716.6 Million for 2009 "

OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) provided an update to the preliminary revenue and adjusted earnings per share growth rate guidance provided to investors at the Company’s recent analyst R&D day meeting on December 3, 2009. The Company now believes that the 2010 overall revenue percentage growth rate will be in the mid-teens and re-affirms that [...]

Continue reading " OSI Pharmaceuticals Updates Preliminary Revenue & Re-affirms Adjusted Earnings Growth Rate Guidance for 2010 "

Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) (Except for Per Share Data or where otherwise noted, Numbers are in Thousands) announced best ever Company quarterly and annual fiscal year results, topping one hundred million in net revenue during the quarter for the first time.

Related posts

Cubist Pharmaceuticals Announces Full Year 2009 Total Net Revenues of $562.1 Million [...]

Continue reading " Bio-Reference Laboratories, Inc. Announces Record Revenues and Earnings for Fourth Quarter and Fiscal Year "

AmerisourceBergen Corporation (NYSE: ABC) will announce at its Investor Meeting in New York City that in the December 2009 quarter, it expects diluted earnings per share to be several cents above the current consensus of $0.43, due primarily to expected revenue growth of more than 10 percent in the December quarter and the contribution from [...]

Continue reading " AmerisourceBergen Expects Strong December 2009 Quarter Pushing Guidance for FY2010 to the Higher End of Its Range "

BioReference Laboratories, Inc. (NASDAQ: BRLI) announced it plans to issue earnings results for the fourth quarter and year end of fiscal 2009 before the open of market trading on Thursday, December 17, 2009. The Company’s earnings conference call is to take place the same day at 10:30 a.m. EST. The call will be hosted by [...]

Continue reading " BioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2009 "

IASIS Healthcare LLC (“IASIS”) announced financial and operating results for the fiscal fourth quarter and year ended September 30, 2009.
Net revenue for the fourth quarter totaled $620.1 million, an increase of 20.3%, compared to $515.4 million in the prior year quarter. Adjusted EBITDA for the fourth quarter totaled $67.9 million, an increase of 17.2%, compared [...]

Continue reading " IASIS Healthcare Announces Fourth Quarter and Year-End 2009 Results "

SeraCare Life Sciences, Inc. (NASDAQ: SRLS), a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, reported operational and financial results for its fourth quarter and fiscal year ended September 30, 2009.
SeraCare delivered revenue of $12.5 million for the quarter ended September 30, [...]

Continue reading " SeraCare Reports Fourth Quarter and Fiscal Year 2009 Results "

SunLink Health Systems, Inc. (NYSE Amex: SSY) announced earnings from continuing operations for its fiscal quarter ended September 30, 2009 of $549,000, or $0.07 per fully diluted share, compared to a loss from continuing operations of $603,000, or $0.08 per fully diluted share, for the quarter ended September 30, 2008. Included in the results for [...]

Continue reading " SunLink Health Systems, Inc. Announces Fiscal 2010 First Quarter Results "

ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of resuscitation devices and software solutions, announced that fiscal 2009 revenues were $385.2 million, compared to fiscal 2008 revenues of $398.0 million, a decline of 3%. Revenue results reflected a negative foreign exchange impact of nearly $12 million compared to fiscal 2008. The results include approximately $6.9 million [...]

Continue reading " ZOLL Medical Corporation Announces Annual Results "